📰 Diffusion Pharmaceuticals News
Page 4 - Diffusion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diffusion Pharmaceuticals. Real-time updates on events, politics, business and more.
June 15, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average […]
June 15, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Wednesday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 2.4 % Shares of Diffusion Pharmaceuticals stock opened at $3.60 on Wednesday. The firm has a market cap of $7.34 million, […]
June 14, 2023
Research Analysts’ new coverage for Wednesday, June 14th: BNP Paribas began coverage on shares of Agree Realty (NYSE:ADC). The firm issued an outperform rating and a $80.00 target price on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares […]
June 14, 2023
Research Analysts’ new coverage for Wednesday, June 14th: BNP Paribas began coverage on shares of Agree Realty (NYSE:ADC). The firm issued an outperform rating and a $80.00 target price on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares […]
June 10, 2023
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Tuesday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.51 on Tuesday. Diffusion Pharmaceuticals has a 1 year low of $3.42 and a 1 […]
June 6, 2023
Stock Analysts’ new coverage for Tuesday, June 6th: StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued a hold rating on the stock. StockNews.com assumed coverage on shares of Aerojet Rocketdyne (NYSE:AJRD). They issued a hold rating on the stock. StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN). They issued a […]
June 2, 2023
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report issued on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.81 on Monday. The stock has a market cap of $7.77 million, a P/E ratio of -0.50 and a beta […]
June 2, 2023
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.81 on Monday. The firm has a fifty day moving average price of $4.10 and a 200 day […]
June 1, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note published on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 1.4 % Diffusion Pharmaceuticals stock opened at $3.88 on Monday. The business has a 50-day simple moving average of $4.14 and a 200 […]
May 25, 2023
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 1.3 % DFFN stock opened at $4.20 on Friday. The stock has a market capitalization of $8.56 million, a P/E ratio […]